A phase IV, randomised, open-label, controlled study to assess the immunogenicity and safety of the diphtheria, tetanus, pertussis and inactivated poliovirus (DPT-IPV) vaccine Squarekids when co-administered with GSK Biologicals' oral live attenuated HRV liquid vaccine Rotarix in healthy Japanese infants aged 6 - 12 weeks at the time of the first dose of HRV vaccination.

Trial Profile

A phase IV, randomised, open-label, controlled study to assess the immunogenicity and safety of the diphtheria, tetanus, pertussis and inactivated poliovirus (DPT-IPV) vaccine Squarekids when co-administered with GSK Biologicals' oral live attenuated HRV liquid vaccine Rotarix in healthy Japanese infants aged 6 - 12 weeks at the time of the first dose of HRV vaccination.

Completed
Phase of Trial: Phase IV

Latest Information Update: 22 Jun 2017

At a glance

  • Drugs Pertussis diptheria tetanus poliovirus vaccine (Squarekids) (Primary) ; RIX 4414 (Primary)
  • Indications Diphtheria; Pertussis; Poliomyelitis; Rotavirus infections; Tetanus
  • Focus Pharmacodynamics
  • Sponsors GlaxoSmithKline Biologicals
  • Most Recent Events

    • 15 Jun 2017 Status changed from active, no longer recruiting to completed.
    • 16 Mar 2017 Planned End Date changed from 17 Jun 2017 to 1 May 2017.
    • 16 Mar 2017 Planned primary completion date changed from 1 Jun 2017 to 1 May 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top